引用本文:宋 默,王洪江.神经生长因子及其受体在肿瘤研究中的进展[J].大连医科大学学报,2010,32(2):219-222.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
神经生长因子及其受体在肿瘤研究中的进展
宋 默, 王洪江
大连医科大学附属第一医院 普外科,辽宁 大连 116011
摘要:
神经生长因子是一种多功能、多肽性的物质,通过特异的靶细胞表面的神经生长因子受体介导产生生物学效应。它对肿瘤细胞主要表现为抗凋亡的活性,具有强烈的促进肿瘤细胞生长的作用,与肿瘤的增殖、分化和转移有着密切的关系。高亲和力受体Trk A 与低亲和力受体p75在癌组织中均表达,研究表明Trk A与p75与肿瘤的预后、分级及肿瘤类型均相关。适当应用p75和Trk A的激动剂或抑制剂,可为更好的治疗肿瘤提供有效的办法。
关键词:  神经生长因子  肿瘤  细胞凋亡
DOI:10.11724/jdmu.2010.02.29
分类号:R329.2
基金项目:
Expressions of nerve growth factor and its receptor in breast cancer and its clinical significance
SONG Mo, WANG Hong-jiang
Department of General Surgery,the First Affiliated Hospital of Dalian Medical University,Dalian 116011,China
Abstract:
Nerve growth factor is a multi-function and multi-peptide material.It produces biological effects through the nerve growth factor receptors on the specific target cell surface.It makes an anti-apoptosis activity to the tumor cells and promotes the growth of tumor cells.Trk A is a high-affinity receptor,influences on the transcription and translation of the cells and controls the growth of the cells.p75 is a low-affinity receptor.They are both expressed in the tumor cells.Many studies have showed that p75 and Trk A are related with the prognosis,grade and type of the tumor cells.The appropriate application of the p75 and Trk A agonists or inhibitors may play an effective solution on the treatment of the tumors.
Key words:  nerve growth factor  tumor  apoptosis